Morpholino

MO3-fgf8a

ID
ZDB-MRPHLNO-050714-1
Name
MO3-fgf8a
Previous Names
  • fgf8 MO (1)
  • MO3-fgf8 (1)
Target
Sequence
5' - GAGTCTCATGTTTATAGCCTCAGTA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO3-fgf8a
Phenotype
Phenotype resulting from MO3-fgf8a
Phenotype of all Fish created by or utilizing MO3-fgf8a
Phenotype Fish Conditions Figures
Kupffer's vesicle cilium decreased length, abnormal WT + MO3-fgf8a standard conditions Fig. 4 with image from Liu et al., 2011
midbrain hindbrain boundary aplastic, abnormal WT + MO3-fgf8a standard conditions Fig. 1 from Araki et al., 2001
Kupffer's vesicle cilium decreased amount, abnormal WT + MO3-fgf8a standard conditions Fig. 4 with image from Liu et al., 2011
brain apoptotic, abnormal WT + MO3-fgf8a standard conditions Fig. 6 with image from Dworkin et al., 2012
cerebellum absent, abnormal WT + MO3-fgf8a standard conditions Fig. 6 with image from Dworkin et al., 2012
ventricular system morphology, abnormal WT + MO3-fgf8a standard conditions Fig. 6 with image from Dworkin et al., 2012
cerebellum aplastic, abnormal WT + MO3-fgf8a standard conditions Fig. 1 from Araki et al., 2001
forerunner cell group distributed, abnormal WT + MO3-fgf8a standard conditions Fig. 3 with image from Matsui et al., 2011
otic vesicle morphology, abnormal pt6Tg + MO3-fgf8a standard conditions Fig. 3 with image from Molina et al., 2007
retina morphology, abnormal pt6Tg + MO3-fgf8a standard conditions Fig. 3 with image from Molina et al., 2007
midbrain hindbrain boundary morphology, abnormal pt6Tg + MO3-fgf8a standard conditions Fig. 3 with image from Molina et al., 2007
closure of optic fissure process quality, ameliorated AB + MO1-adamts16 + MO3-fgf8a standard conditions Fig. 5 with image from Cao et al., 2018
closure of optic fissure process quality, ameliorated AB + MO2-adamts16 + MO3-fgf8a standard conditions Fig. 5 with image from Cao et al., 2018
epibranchial field pax2a expression absent, abnormal WT + MO1-fgf3 + MO3-fgf8a standard conditions Fig. 5 with image from Sun et al., 2007
epibranchial field sox3 expression absent, abnormal WT + MO1-fgf3 + MO3-fgf8a standard conditions Fig. 5 with image from Sun et al., 2007
midbrain development disrupted, abnormal WT + MO1-fgf3 + MO3-fgf8a standard conditions Fig. 9 with image from Miyake et al., 2014
presumptive paraxial mesoderm myf5 expression decreased distribution, abnormal WT + MO1-fgf6a + MO3-fgf8a standard conditions Fig. 3 with image from Osborn et al., 2020
presumptive paraxial mesoderm myod1 expression decreased distribution, abnormal WT + MO1-fgf6a + MO3-fgf8a standard conditions Fig. 3 with image from Osborn et al., 2020
Kupffer's vesicle cilium decreased length, abnormal WT + MO1-fgf24 + MO3-fgf8a standard conditions Fig. 4 with image from Liu et al., 2011
Kupffer's vesicle cilium decreased amount, abnormal WT + MO1-fgf24 + MO3-fgf8a standard conditions Fig. 4 with image from Liu et al., 2011
brain apoptotic, abnormal WT + MO2-grhl2a + MO3-fgf8a standard conditions Fig. 6 with image from Dworkin et al., 2012
ventricular system morphology, abnormal WT + MO2-grhl2a + MO3-fgf8a standard conditions Fig. 6 with image from Dworkin et al., 2012
midbrain hindbrain boundary absent, abnormal WT + MO2-grhl2a + MO3-fgf8a standard conditions Fig. 6 with image from Dworkin et al., 2012
midbrain-hindbrain boundary morphogenesis disrupted, abnormal WT + MO2-grhl2a + MO3-fgf8a standard conditions Fig. 6 with image from Dworkin et al., 2012
pancreas mislocalised, abnormal WT + MO3-fgf4 + MO3-fgf8a standard conditions Fig. 2 with image from Yamauchi et al., 2009
liver mislocalised, abnormal WT + MO3-fgf4 + MO3-fgf8a standard conditions Fig. 2 with image from Yamauchi et al., 2009
determination of pancreatic left/right asymmetry disrupted, abnormal WT + MO3-fgf4 + MO3-fgf8a standard conditions Fig. 2 with image from Yamauchi et al., 2009
determination of liver left/right asymmetry disrupted, abnormal WT + MO3-fgf4 + MO3-fgf8a standard conditions Fig. 2 with image from Yamauchi et al., 2009
presumptive paraxial mesoderm myf5 expression decreased distribution, abnormal WT + MO3-fgf8a + MO5-fgf4 standard conditions Fig. 3 with image from Osborn et al., 2020
presumptive paraxial mesoderm myod1 expression absent, abnormal WT + MO3-fgf8a + MO5-fgf4 standard conditions Fig. 3 with image from Osborn et al., 2020
segmental plate adaxial cell myod1 expression decreased distribution, abnormal WT + MO3-fgf8a + MO5-fgf4 chemical treatment: Cyclopamine Fig. 3 with image from Osborn et al., 2020
paraxial mesoderm myod1 expression absent, abnormal WT + MO3-fgf8a + MO5-fgf4 chemical treatment: Cyclopamine Fig. 3 with image from Osborn et al., 2020
presumptive paraxial mesoderm myod1 expression absent, abnormal WT + MO1-fgf6a + MO3-fgf8a + MO5-fgf4 standard conditions Fig. 3 with image from Osborn et al., 2020
presumptive paraxial mesoderm myf5 expression decreased distribution, abnormal WT + MO1-fgf6a + MO3-fgf8a + MO5-fgf4 standard conditions Fig. 3 with image from Osborn et al., 2020
Citations